Skip to content

Clinical trials

Completed Phase 1 Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1 Status: Completed Clear all

365 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200012
20016
20027
20037
20047
200511
200612
200723
200816
200911
201015
201125
201212
201316
201422
201513
201615
201728
201823
201916
20208
202113
20226
20236
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed365

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)27
Memorial Sloan Kettering Cancer Center15
Gynecologic Oncology Group11
AstraZeneca9
M.D. Anderson Cancer Center9
AbbVie8
Ludwig Institute for Cancer Research7
Mayo Clinic7
Celldex Therapeutics6
Astellas Pharma Inc5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms365
Breast Neoplasms122
Fallopian Tube Neoplasms90
Carcinoma, Non-Small-Cell Lung75
Carcinoma, Ovarian Epithelial65
Colorectal Neoplasms63
Pancreatic Neoplasms60
Lung Neoplasms57
Neoplasms52
Prostatic Neoplasms46

Trials

Showing 1 to 25 of 365. Each trial links to its page on Pharma Observatory.

265 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.